Mikart Marks a New Era with Ribbon Cutting of New Headquarters in Atlanta

Mikart's New Headquarters Celebrated in Atlanta

On April 28, 2026, Mikart, a prominent contract development and manufacturing organization (CDMO), held a ceremonial ribbon cutting to commemorate the opening of its new executive headquarters located in Northwest Atlanta. This development marks a significant milestone in the company's expansion and growth strategy.

The decision to relocate was initially announced in September 2025, as Mikart aimed to create a modern, centralized hub that supports its continually expanding operations. Designed with several collaborative workspaces, the new headquarters aims to streamline operations while preparing for future growth. The importance of this move is underscored by CEO Michael Kallelis, who stated, _"This ribbon cutting marks an exciting new chapter for Mikart. Our new headquarters provides the space and infrastructure needed to support our growing team and evolving business while reinforcing our commitment to operational excellence and innovation."_

In tandem with the headquarters opening, Mikart is also gearing up for a major expansion of its manufacturing capabilities. This initiative focuses specifically on oral solid dosage (OSD) bottling and downstream packaging operations, which is set to increase their bottling capacity by over 50%. This enhancement will position them to better meet the rising demand from partners and facilitate future progress in the industry.

The completion of the manufacturing expansion project is expected in the fourth quarter of 2026, with operations slated to begin shortly after. This strategic initiative is aimed at fortifying Mikart's CDMO manufacturing network, improving resilience and capacity while enabling scalable long-term growth.

Scott Neola, CFO of Mikart, also emphasizes the significance of this dual initiative when he remarked, _"The combination of our new headquarters and expanded manufacturing capabilities positions Mikart for continued, sustainable growth. We are making disciplined investments to strengthen our infrastructure, improve efficiency, and ensure we can scale alongside our partners."_

The company’s commitment to its Atlanta base remains strong, as their headquarters and manufacturing operations continue to be situated there. This steadfast dedication supports their role in uplifting the local economy while being integral to their long-term business strategy.

Mikart is recognized as a full-service CDMO specializing in oral solid dosage forms and comprehensive pharmaceutical solutions. The organization collaborates with its clients to deliver top-tier development, manufacturing, and packaging services, focusing on reliability, flexibility, and sustained success within the industry.

Conclusion

In summary, the opening of Mikart's new headquarters is not just about moving to a new location but symbolizes a significant advancement in the company’s mission to deliver quality services while ensuring their operations align with innovative practices in the pharmaceutical sector. This move is expected to bring numerous benefits to both the organization and its clients, leading to enhanced partnerships and growth opportunities.